TLR2 and Lewy body dementia: Together, these results show comparable increases of TLR2 expression in neurons and glial cells in PD/DLB patients and in the high expresser α-Syn-tg mice and provides rationale to the notion that blocking TLR2 with neutralizing antibodies might be of therapeutic value.